Literature DB >> 1783004

Regulation of G proteins by chronic antidepressant drug treatment in rat brain: tricyclics but not clorgyline increase Go alpha subunits.

K P Lesch1, C S Aulakh, T J Tolliver, J L Hill, D L Murphy.   

Abstract

The effect of long-term (3-week) administration of various antidepressant drugs on the steady-state concentrations of G protein alpha subunits, Gs alpha, Gi alpha, and Go alpha, has been investigated in rat brain using an enzyme-linked immunosorbent assay. Tricyclic antidepressants and clorgyline decreased Gs alpha and, to a lesser extent, Gi alpha in several brain regions, while Go alpha was increased by tricyclics but not clorgyline. We conclude that long-term treatment with antidepressant drugs exerts differential effects on G protein alpha subunits, and that antidepressant efficacy may potentially be based on functional modifications of signal transduction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1783004     DOI: 10.1016/0922-4106(91)90012-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Is there action beyond receptors?

Authors:  P D Hrdina
Journal:  J Psychiatry Neurosci       Date:  1993-03       Impact factor: 6.186

2.  [On a new pharmacological action of antidepressants].

Authors:  M Bourin
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

3.  Effects of subchronic administration of antidepressants and anxiolytics on levels of the alpha subunits of G proteins in the rat brain.

Authors:  Y Dwivedi; G N Pandey
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo: effect of chronic antidepressant drug treatment.

Authors:  T J Sayer; S D Hannon; P H Redfern; K F Martin
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

5.  Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients.

Authors:  H Ozawa; W Gsell; L Frölich; R Zöchling; F Pantucek; H Beckmann; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1993

6.  Heterotrimeric g proteins: insights into the neurobiology of mood disorders.

Authors:  Javier González-Maeso; J Javier Meana
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

7.  5-HT1A receptor-effector system responsivity in panic disorder.

Authors:  K P Lesch; M Wiesmann; A Hoh; T Müller; J Disselkamp-Tietze; M Osterheider; H M Schulte
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.

Authors:  A Lucchelli; M G Santagostino-Barbone; A Barbieri; S M Candura; M Tonini
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

9.  Alterations in hippocampal serotonergic and INSR function in streptozotocin induced diabetic rats exposed to stress: neuroprotective role of pyridoxine and Aegle marmelose.

Authors:  Pretty Mary Abraham; Korah P Kuruvilla; Jobin Mathew; Anitha Malat; Shilpa Joy; C S Paulose
Journal:  J Biomed Sci       Date:  2010-09-25       Impact factor: 8.410

Review 10.  The Role of G-proteins and G-protein Regulating Proteins in Depressive Disorders.

Authors:  Nicolas B Senese; Mark M Rasenick; John R Traynor
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.